Myocardial injury in meningococcus-induced purpura fulminans in children

G Briassoulis1, M Narlioglou, N Zavras

  • 1Pediatric Intensive Care Unit, Aghia Sophia Children's Hospital, Athens, Greece. briassg@otenet.gr

Intensive Care Medicine
|August 11, 2001
PubMed

Insights

Myocardial ischemia is common in pediatric meningococcemia, indicated by elevated cardiac troponin I (cTnI). High cTnI levels correlate with coagulopathy and impaired heart function, suggesting a need for early intervention.

Area of Science:

  • Pediatric Cardiology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Meningococcemia can lead to severe complications, including purpura fulminans.
  • Myocardial involvement in pediatric meningococcemia is not well-characterized.

Purpose of the Study:

  • To determine the incidence of myocardial ischemia in pediatric patients with meningococcus-induced purpura fulminans.
  • To correlate cardiac troponin I (cTnI) levels with electrocardiogram (ECG) changes, myocardial function, and coagulopathy.
  • To evaluate the relationship between cTnI and disease severity.

Main Methods:

  • Studied 22 pediatric patients with acute meningococcemia requiring inotropic or vasoactive support.
  • Daily monitoring of serum cTnI, myocardial ischemia markers, and coagulopathy markers.
  • Daily measurements of cardiac index, ejection fraction, shortening fraction, and ECGs.

Main Results:

  • Five patients (23%) presented with myocardial ischemia, characterized by elevated cTnI levels and depressed myocardial contractility.
  • High cTnI levels correlated significantly with low levels of protein C, factor VIII, and antithrombin III.
  • Myocardial ischemia was not associated with clinical prognostic scores or inotropic support.

Conclusions:

  • Myocardial ischemia is increased in pediatric acute meningococcemia and linked to myocardial dysfunction.
  • Elevated cTnI indicates severe coagulopathy but not necessarily poor prognosis based on clinical scores.
  • Early detection of myocardial injury and prompt replacement therapy may improve outcomes.
Abstract

Related Concept Videos

Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...